What is the recommended analgesic dosing regimen for ketamine (including IV, IM, and oral routes)?

Analgesic Dose of Ketamine

For acute pain management, administer IV ketamine at 0.5 mg/kg as a bolus dose (or 0.25-0.5 mg/kg for S-ketamine), which can be followed by continuous infusion at 0.1-0.2 mg/kg/hour (maximum 0.4 mg/kg/hour) for sustained analgesia. 1

Intravenous Administration

Acute Pain (Emergency Department/Perioperative)

• Bolus dosing: 0.5 mg/kg IV for breakthrough pain, titrated to effect 1
• Low-dose ketamine: 0.1-0.3 mg/kg provides effective analgesia with fewer adverse effects compared to higher doses 2, 3
• Continuous infusion: 0.1-0.5 mg/minute (or 0.1-0.2 mg/kg/hour) for maintenance analgesia 4
• Administration rate: Administer slowly over 60 seconds to minimize respiratory depression and pressor response 4

Pediatric Dosing

• Intraoperative adjunct: 0.5 mg/kg bolus (0.25-0.5 mg/kg for S-ketamine), followed by optional continuous infusion of 0.1-0.2 mg/kg/hour (maximum 0.4 mg/kg/hour) 1
• Breakthrough pain in PACU: 0.5 mg/kg, titrated to effect 1
• Reduced dose for S-ketamine: Consider 0.25-0.5 mg/kg when using the S-enantiomer due to increased potency 1

Opioid-Sparing Strategy

• Adjunct to opioids: Ketamine 0.5 mg/kg reduces total opioid requirements by 25-30% 5, 6
• Remifentanil-based anesthesia: Ketamine is first-line anti-hyperalgesic agent, reducing 24-hour morphine consumption by approximately 15 mg 6
• Timing: Administer after anesthesia induction to prevent psychodysleptic side effects 6

Intramuscular Administration

• Anesthetic dose range: 6.5-13 mg/kg IM produces surgical anesthesia within 3-4 minutes, lasting 12-25 minutes 4
• Standard dose: 10 mg/kg (5 mg/lb) typically used 4
• Analgesic dose: 0.5 mg/kg IM provides analgesia with plasma concentration of 150 ng/mL 7

Oral Administration

Chronic Pain Management

• Starting dose: 0.5 mg/kg as single oral dose for ketamine-naive patients (0.25 mg/kg for S-ketamine) 8
• Titration: Increase by same amount (0.5 mg/kg increments) if required 8
• Maintenance dosing: Typically given 3-4 times daily for continuous analgesic effect 8
• Effective daily dose: Mean of 2 mg/kg/day (range 1.5-3.0 mg/kg/day) divided into 3-4 doses 9

Conversion from IV to Oral

• Equal daily dosage: When switching from parenteral to oral, maintain the same total daily dose initially 8
• Subsequent titration: Slowly increase based on clinical effect and adverse effects 8
• Bioavailability consideration: Oral ketamine has lower bioavailability but higher norketamine metabolite concentrations (which contributes to analgesia), requiring plasma concentration of only 40 ng/mL versus 150 ng/mL for IM route 7

Practical Administration

• Formulation: Injectable ketamine solution can be taken orally 8
• Incremental increases: For direct oral treatment, start with 0.5 mg/kg, then increase in 15-20 mg increments 9

Critical Safety Considerations

Monitoring Requirements

• Continuous monitoring: Oxygen saturation, blood pressure, heart rate, and respiratory rate mandatory throughout administration 1, 5, 10
• Respiratory depression: Approximately 10% of patients receiving higher doses (>1.5 mg/kg total) develop persistent postoperative respiratory depression 5, 10, 6
• Duration of monitoring: Continue for at least 2 hours postoperatively, as respiratory depression may outlast analgesic effects 5, 10

Adverse Effects Management

• Common side effects: Agitation (7.3%) and nausea (7.0%) most frequent 2
• Dysphoria and dizziness: More common with low-dose ketamine but generally minor 3
• Psychodysleptic effects: Reduced by administering after anesthesia induction and using multimodal approach 6
• Naloxone availability: Keep 0.2-0.4 mg immediately available, though it does not reverse ketamine effects directly 5, 10

Administration Precautions

• Dilution requirement: The 100 mg/mL concentration must be diluted before IV use with equal volume of sterile water, normal saline, or 5% dextrose 4
• Supported position: Patient should be in supported position during IV administration due to rapid onset 4
• Aspiration risk: Consider aspiration potential; atropine or drying agent should be given at appropriate interval prior to induction 4
• Post-administration restrictions: Advise patients not to drive or operate hazardous machinery within 24 hours 11

Dose-Response Relationships

Efficacy Comparison

• Low-dose (<0.3 mg/kg) versus high-dose (≥0.3 mg/kg): Both provide similar pain relief (mean NRS reduction -2.2 vs -2.6) with similar adverse effect profiles 2
• Optimal ED dosing: Low-dose ketamine <0.3 mg/kg is effective and safe for acute pain management 2
• Adjunct to morphine: 0.3 mg/kg may be more effective than 0.15 mg/kg for sustained pain reduction up to 2 hours 3

Clinical Outcomes

• Chronic pain effectiveness: Effective in 44% of patients (mean pain reduction 67±17%), partially effective in 20% (mean pain reduction 30±11%) 9
• Opioid-sparing effect: Mean opioid reduction of 63±32% in chronic pain patients 9
• Better outcomes with concurrent opioids: Failure rate lower (7% vs 36%) and fewer adverse effects (33% vs 68%) when ketamine combined with opioid therapy 9

Common Pitfalls to Avoid

• Rapid IV administration: Causes respiratory depression and enhanced pressor response; always administer over 60 seconds 4
• Underdosing for analgesia: Sub-analgesic doses provide inadequate pain relief; ensure minimum 0.5 mg/kg for acute pain 1
• Mixing with diazepam: Never mix ketamine and diazepam in same syringe due to chemical incompatibility and precipitate formation 4
• Inadequate monitoring: Failure to monitor for respiratory depression beyond immediate post-administration period 5, 10, 6
• Ignoring S-ketamine potency: S-ketamine requires 50% dose reduction (0.25-0.5 mg/kg) compared to racemic ketamine 1